In collaboration with our partner, the Embassy of Canada to the Netherlands, we presented the webinar:
Does COVID-19 shape the future of vaccine development?
This webinar was presented jointly by companies and Key Opinion Leaders:
> International Vaccine Institute: Prof. Jerome Kim
> Janssen: Hanneke Schuitemaker, Ph.D
> Medicago: Nathalie Charland, Ph.D
> Clinical Trials Ontario: Andrew Haller, Ph.D
> Julius Clinical: Prof. Rick Grobbee
During this webinar they covered:
> Status quo and new developments including novel vaccine platforms as mRNA
> Speedy developments through the COVID-19 situation
> COVID-19 vaccine development in the mRNA, Adeno and protein-based vaccine space
> Regulatory hurdles and opportunities
> Clinical trial space (hurdles and chances)
> COVID-19: Impact for other vaccine developments
The replay will available soon.